X4 PHARMACEUTICALS, INC (XFOR) Free cash flow 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$85.6MFY2025 · since FY2016: -$21.7M → -$85.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.6M | +34.8% |
| FY2024 | -$131.2M | -35.9% |
| FY2023 | -$96.6M | -25.1% |
| FY2022 | -$77.2M | -7.9% |
| FY2021 | -$71.5M | -18.8% |
| FY2020 | -$60.2M | -24.8% |
| FY2019 | -$48.2M | -89.7% |
| FY2018 | -$25.4M | -17.2% |
| FY2017 | -$21.7M | +0.1% |
| FY2016 | -$21.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Gross marginXFOR Operating incomeXFOR Operating marginXFOR Operating cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →